Valuation: ResMed, Inc.

Market Cap 35.56B 31.76B 29.34B 26.59B 49.74B 3,376B 50.56B 353B 140B 1,769B 133B 131B 5,576B P/E 2027 *
21.7x
P/E 2028 * 19.7x
Enterprise Value 34.56B 30.86B 28.51B 25.83B 48.33B 3,280B 49.13B 343B 136B 1,719B 130B 127B 5,419B EV / Sales 2027 *
5.95x
EV / Sales 2028 * 5.5x
Free-Float
74.65%
Yield 2027 *
1.06%
Yield 2028 * 1.15%
1 day-0.08%
1 week+5.81%
Current month+14.36%
1 month+13.96%
3 months+29.49%
6 months+15.01%
Current year+4.98%
1 week 235.5
Extreme 235.5
255.56
1 month 218.03
Extreme 218.03
255.56
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
277.67
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
293.81
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2013
Director of Finance/CFO 41 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 54 25/01/2023
Chairman 84 01/06/1989
Date Insider Type Main position Quantity % Market Cap. Importance
7/10/26 Exercice

Chief Executive Officer

14,973 0.0104%
8/9/26 Exercice

Chief Executive Officer

14,973 0.0104%
8/9/26 Other

Chief Executive Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-0.08%+5.81%-2.56%+77.73% 35.56B
-0.40%-2.34%+17.70%+47.04% 249B
+0.33%+0.64%+3.36%+17.10% 162B
+1.90%+6.00%-17.24%+63.05% 157B
-0.70%+2.93%-54.81%-10.34% 66.22B
+0.15%+4.09%+10.25%+63.82% 52.3B
+0.24%+0.99%-15.49%-12.11% 52.18B
-1.13%+2.85%+17.04%+26.36% 51.34B
-0.47%+0.06%+16.92%+63.83% 48.79B
-0.42%+3.83%+26.19%+82.07% 44.57B
Average -0.06%+2.62%+0.14%+41.85% 91.91B
Weighted average by Cap. +0.13%+1.67%+1.23%+40.57%

Financials

2027 *2028 *
Net sales 5.8B 5.18B 4.79B 4.34B 8.12B 551B 8.25B 57.61B 22.81B 289B 21.78B 21.32B 910B 6.18B 5.52B 5.1B 4.62B 8.64B 587B 8.79B 61.34B 24.28B 307B 23.19B 22.7B 969B
Net income 1.64B 1.47B 1.36B 1.23B 2.3B 156B 2.34B 16.31B 6.46B 81.72B 6.17B 6.03B 258B 1.78B 1.59B 1.47B 1.33B 2.5B 169B 2.54B 17.71B 7.01B 88.75B 6.7B 6.55B 280B
Net Debt -1.01B -898M -830M -752M -1.41B -95.48B -1.43B -9.98B -3.95B -50.02B -3.77B -3.69B -158B -1.56B -1.4B -1.29B -1.17B -2.19B -148B -2.22B -15.52B -6.14B -77.76B -5.87B -5.74B -245B
Projected Income Statement - Annual - ResMed, Inc.
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
23/10/26 USD 252.86 -0.08% 1,032,414
22/10/26 USD 253.06 +2.79% 1,728,824
21/10/26 USD 246.20 +0.29% 899,292
20/10/26 USD 245.50 +2.39% 1,245,217
19/10/26 USD 239.77 +0.33% 932,294
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - ResMed, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
252.86USD
Average target price
251.52USD
Spread / Average Target
-0.53%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ResMed, Inc.